Testosterone propionate
General information:
| Withdrawn ID: | 144 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | G03BA03 |
| Molecular Formula: | C22H32O3 |
| Molweight: | 344.488 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1974 |
| First withdrawn: | 1982 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Testosterone propionate as primary suspect: | 3 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 2 |
|---|---|
| Life-Threatening condition: | 1 |
| Intervention required to prevent permanent impairment/damage: | 1 |
| Death: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| VENTRICULAR TACHYCARDIA | 1 |
| VENTRICULAR HYPOKINESIA | 1 |
| VENTRICULAR HYPERTROPHY | 1 |
| RESPIRATORY FAILURE | 1 |
| POST PROCEDURAL COMPLICATION | 1 |
| PENIS DISORDER | 1 |
| Injection site swelling | 1 |
| Injection site pain | 1 |
| DRUG WITHDRAWAL SYNDROME | 1 |
| DERMAL CYST | 1 |
| CARDIAC ARREST | 1 |
| AORTIC STENOSIS | 1 |
| ANAESTHETIC COMPLICATION CARDIAC | 1 |
Filtered ChEMBL targets:
| Target UniProtKB ID | Activity in nm | Target Name | Target gene |
|---|---|---|---|
| P02545 | 7.9 | Prelamin-A/C | LMNA_HUMAN |
| P10275 | 0.25 | Androgen receptor | ANDR_HUMAN |
Toxicity information:
| Toxicity class: | 4 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 1000 mg/kg |
External links:
| ChEBML: | CHEMBL1170 |
|---|---|
| DrugBank: | DB01420 |